Health In Tech (HIT) Q2 2026 Earnings Call Transcript
Health In Tech (HIT) reported Q2 2026 revenue of $8.1M, down 13.5% YoY due to policy timing shifts. Distribution partners grew 19.9% to 933. Contracted revenue was $32.3M, with $14M expected in H2 2026. Pipeline revenue reached $66.3M. Adjusted EBITDA was -$1.3M, and net loss was $2.5M. Management reaffirmed full-year guidance of $45M-$50M revenue, citing strong pipeline visibility. The company is investing in sales, marketing, and technology upgrades, including the upcoming HitRix platform for
How this was made
The 30-second read
Why it matters
Earnings miss and loss widen may trigger short‑term sell pressure, but long‑term growth prospects remain tied to carrier upgrades and AI platform rollout.
Market read
Micro‑cap health‑tech stock with new earnings data; relevance primarily to niche investors.
What to watch
Potential upside from securing A‑rated carrier status and AI‑driven platform launch later in 2026.
Background
Health In Tech, Inc. provides a cloud platform for self‑funded stop‑loss insurance, reporting its Q2 2026 results.
Ticker impact
Q2 2026 earnings release shows revenue down 13.5% to $8.1M, negative adjusted EBITDA and reaffirmed FY guidance.
Potential downside of 5-10% over the next week.
Revenue decline and loss widen, but guidance remains unchanged; market may react negatively.
Market effects
Highlights challenges in the health‑tech insurance platform space, may affect peer valuations.
Limited to US micro‑cap segment.
Low
Counterpoint
Guidance reaffirmed and pipeline growth could support a bounce if market overreacts.
Key entities
- ExecutiveTim Johnson
CEO of Health In Tech, Inc.
- ExecutiveJulia Qian
CFO of Health In Tech, Inc.
